Want to join the conversation?
$CBM agreed to buy privately-owned PharmaCore, which specializes in developing, manufacturing and scaling up small molecule Active Pharmaceutical Ingredients (APIs) for clinical phase projects, for about $25MM. $CBM expects deal, net of deal fees, to have neutral impact on EPS in 2016 and to be accretive in 2017. The deal will close within 30 days.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.